Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate

Yildirim, Berna; Onal, Cem; Kose, Fatih; Oymak, Ezgi; Sedef, Ali; Besen, Ali; AKSOY, SERCAN; Guler, Ozan; Sumbul, Ahmet; Muallaoglu, Sadik; Mertsoylu, Huseyin; ÖZYİĞİT, GÖKHAN

doi:10.1007/s00066-019-01429-6

Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate

Copy For Citation

Yildirim B. A., Onal C., Kose F., Oymak E., Sedef A. M., Besen A. A., ...More

STRAHLENTHERAPIE UND ONKOLOGIE, vol.195, no.10, pp.872-881, 2019 (SCI-Expanded)

Publication Type: Article / Article
Volume: 195 Issue: 10
Publication Date: 2019
Doi Number: 10.1007/s00066-019-01429-6
Journal Name: STRAHLENTHERAPIE UND ONKOLOGIE
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.872-881
Hacettepe University Affiliated: Yes

Abstract

Purpose To evaluate the potential benefit of curative radiotherapy (RT) to the primary tumor in metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone.